Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Collins

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Generating 'omic knowledge': the role of informatics in high content screeningMark A Collins
Drug Discovery Today|April 11, 2013
The HCS data challengeMark A Collins
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
Overview of informatics for high content screeningR Terry Dunlay, Wallace J Czekalski, Mark A Collins
The Journal of Organic Chemistry|October 24, 2001
Furan-Terminated N-Acyliminium Ion Initiated Cyclizations in Alkaloid SynthesisSteven P. Tanis, Melissa V. Deaton, Lisa A. Dixon, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Novel pyrrole-containing progesterone receptor modulatorsMark A Collins, Valerie Hudak, Reinhold Bender, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindolesAndrew Fensome, Reinhold Bender, Jeffrey Cohen, et al.
Journal of Medicinal Chemistry|August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaprogetAndrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Generating 'omic knowledge': the role of informatics in high content screeningMark A Collins
Drug Discovery Today|April 11, 2013
The HCS data challengeMark A Collins
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
Overview of informatics for high content screeningR Terry Dunlay, Wallace J Czekalski, Mark A Collins
The Journal of Organic Chemistry|October 24, 2001
Furan-Terminated N-Acyliminium Ion Initiated Cyclizations in Alkaloid SynthesisSteven P. Tanis, Melissa V. Deaton, Lisa A. Dixon, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Novel pyrrole-containing progesterone receptor modulatorsMark A Collins, Valerie Hudak, Reinhold Bender, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindolesAndrew Fensome, Reinhold Bender, Jeffrey Cohen, et al.
Journal of Medicinal Chemistry|August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaprogetAndrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
Pageof 1